| Lesiak, Maciej |
MATRIX-2, NCT05955365: Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation |
|
|
| Recruiting | 4 | 3010 | Europe | P2Y12 inhibitor, Aspirin, DOAC | Insel Gruppe AG, University Hospital Bern, Sahajanand Medical Technologies Limited | Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation, P2Y12 Inhibitor | 09/26 | 12/26 | | |
NCT03022851: The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension |
|
|
| Recruiting | N/A | 30 | Europe, RoW | Occlutech AFR Device | Occlutech International AB | Pulmonary Hypertension | 02/23 | 12/23 | | |
CAPTURE2, NCT03892824: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants |
|
|
| Active, not recruiting | N/A | 100 | Europe, RoW | Vine™ Embolic Protection System | Javelin Medical, Genae | Atrial Fibrillation, Stroke | 11/22 | 10/24 | | |
| Recruiting | N/A | 250 | Europe, RoW | CTO PCI using DCB-only strategy | National Institute of Cardiology, Warsaw, Poland | Coronary Artery Disease, Total Occlusion of Coronary Artery | 02/25 | 03/25 | | |
| Not yet recruiting | N/A | 321 | Europe, RoW | Paclitaxel drug-coated balloons, Sirolimus drug-coated balloons, New generation drug-eluting stent | Fondazione Ricerca e Innovazione Cardiovascolare ETS | Coronary Artery Disease, DCB | 02/26 | 02/28 | | |
| Active, not recruiting | N/A | 3326 | Europe, RoW | SELUTION SLR, DES | M.A. Med Alliance S.A. | Coronary Artery Disease | 08/25 | 07/30 | | |
| Więckiewicz, Mieszko |
NCT03421028: Evaluation of Biofeedback Therapy Efficiency in Masticatory Muscles Pain Management |
|
|
| Not yet recruiting | N/A | 60 | Europe | Electromyography Biofeedback, EMG-Biofeedback, Classic treatment for myogenous TMD | Wroclaw Medical University | Muscle Pain, Feedback, Psychological, Craniomandibular Disorders, Temporomandibular Disorder, Sleep | 09/23 | 12/24 | | |
| Wieckiewicz, Mieszko |
NCT05214924: Effectiveness of iPRF Injections in Temporomandibular Joints Degeneration Management |
|
|
| Enrolling by invitation | 2/3 | 42 | Europe | Injectable platelet-rich fibrin, iPRF, Platelet-rich plasma, PRP | Wroclaw Medical University | Temporomandibular Disorder, Temporomandibular Joint Disorders, Temporomandibular Arthritis, Temporomandibular Joint Osteoarthritis | 12/24 | 12/25 | | |
| Enrolling by invitation | N/A | 100 | Europe | Opipramol | Wroclaw Medical University | Sleep Bruxism, Hypertension, Thyroid Dysfunction, Mental Status Change, Sleep Apnea, Sleep Disorders, Cardiovascular Risk Factor, Cardiovascular Diseases, Temporomandibular Disorder | 12/24 | 12/24 | | |
NCT04214561: Relationship Between Selected Parameters and Bruxism |
|
|
| Enrolling by invitation | N/A | 50 | Europe | Polysomnography | Wroclaw Medical University | Sleep Bruxism, Sleep Disorder, Psychosomatic Disorder, Pain, Anxiety, Mental Status Change, Temporomandibular Disorder | 12/24 | 12/24 | | |
| Martynowicz, Helena |
COMISA, NCT04937036: Impact of Bruxism Related Arousals on Cardiovascular Risk in Co-morbid Insomnia and Sleep Apnea |
|
|
| Enrolling by invitation | N/A | 120 | Europe | Polysomnography | Wroclaw Medical University | Sleep Apnea, Sleep Bruxism, Sleep Disorder, Insomnia, Comorbidities and Coexisting Conditions, Cardiovascular Diseases | 06/24 | 12/24 | | |
| Enrolling by invitation | N/A | 100 | Europe | Opipramol | Wroclaw Medical University | Sleep Bruxism, Hypertension, Thyroid Dysfunction, Mental Status Change, Sleep Apnea, Sleep Disorders, Cardiovascular Risk Factor, Cardiovascular Diseases, Temporomandibular Disorder | 12/24 | 12/24 | | |
NCT04214561: Relationship Between Selected Parameters and Bruxism |
|
|
| Enrolling by invitation | N/A | 50 | Europe | Polysomnography | Wroclaw Medical University | Sleep Bruxism, Sleep Disorder, Psychosomatic Disorder, Pain, Anxiety, Mental Status Change, Temporomandibular Disorder | 12/24 | 12/24 | | |
| Kübler, Piotr |
NCT03361046: Polish Transcatheter Aortic Valve-in-Valve Implantation (ViV-TAVI) Registry |
|
|
| Recruiting | N/A | 150 | Europe | Transcatheter Aortic Valve-in-Valve Implantation (ViV-TAVI), Transcatheter Aortic Valve-in-Valve Replacement (ViV-TAVR) | Medical University of Warsaw | Aortic Valve Stenosis, Aortic Valve Insufficiency, Ventricular Outflow Obstruction, Left | 12/23 | 05/24 | | |
| Teles, Rui |
NCT04703699: Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis. |
|
|
| Recruiting | N/A | 200 | Europe, RoW | Myval Transcatheter Heart Valve Series, Myval THV | Meril Life Sciences Pvt. Ltd. | Aortic Valve Stenosis | 05/24 | 11/28 | | |
| Completed | N/A | 172 | Europe | FFR-guided PCI and TAVI, CABG and SAVR | Maatschap Cardiologie Zwolle, Medtronic | Aortic Stenosis, Multi Vessel Coronary Artery Disease, TAVI, CABG, PCI, Fractional Flow Reserve | 06/24 | 06/24 | | |
| Recruiting | N/A | 150 | Europe, Canada, RoW | Elective redo transcatheter aortic valve implantation (redo-TAVI), redo-TAVI, redo-TAVR, Valve-in-Valve (ViV), TAV-in-TAV, TAVR-in-TAVR, Revalve | Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences | Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction, Prosthesis Failure | 09/25 | 12/26 | | |
| Recruiting | N/A | 1000 | Europe, Japan | Navitor Transcatheter Aortic Valve, FlexNav Delivery System, Navitor Loading System | Abbott Medical Devices | Aortic Stenosis | 01/26 | 12/30 | | |
| Recruiting | N/A | 400 | Europe, Canada, US | Evolut R/PRO bioprosthesis, Edwards Sapien S3/Ultra bioprosthesis | Erasmus Medical Center | Valve Heart Disease | 05/26 | 05/26 | | |
| Stawarski, Andrzej |
| Recruiting | 3 | 120 | Europe, Canada, Japan, US, RoW | Vedolizumab IV, ENTYVIO, KYNTELES, MLN0002 | Takeda, Takeda Development Center Americas, Inc. | Crohn's Disease (CD) | 11/24 | 11/24 | | |
| Active, not recruiting | 3 | 121 | Europe, Canada, Japan, US, RoW | Vedolizumab, MLN0002, ENTYVIO, KYNTELES | Takeda, Takeda Development Center Americas, Inc. | Colitis, Ulcerative | 08/25 | 08/25 | | |
| Ludwikowska, Kamila |
| Recruiting | N/A | 1000 | Europe | multisystem inflammatory syndrome in children (MIS-C) | Medical University of Warsaw, Wrocław Medical University, University of Warsaw | Covid19 | 05/25 | 08/25 | | |
| Szulc, Małgorzata |
SCALP2, NCT05914805: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss |
|
|
| Recruiting | 3 | 726 | Europe, US | Clascoterone 5% solution, CB-03-01 5% solution, Vehicle solution, Vehicle | Cassiopea SpA, Ergomed PLC, Pharmapace Inc, Canfield Scientific Inc., ICON Clinical Research | Alopecia, Androgenetic | 08/24 | 03/25 | | |
NCT04862819: Evaluation of a New Local Drug Delivery in the Nonsurgical Treatment of Periodontitis |
|
|
| Recruiting | 2 | 60 | Europe | new local drug delivery, New LDD, scaling root planing, Scaling root planing (gold standard treatment) | Wroclaw Medical University | Periodontitis | 11/21 | 12/21 | | |
| konopka, tomasz |
NCT04862819: Evaluation of a New Local Drug Delivery in the Nonsurgical Treatment of Periodontitis |
|
|
| Recruiting | 2 | 60 | Europe | new local drug delivery, New LDD, scaling root planing, Scaling root planing (gold standard treatment) | Wroclaw Medical University | Periodontitis | 11/21 | 12/21 | | |
| Raciborska, Anna |
HISTIOGEN, NCT04943211: Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging |
|
|
| Recruiting | 3 | 150 | Europe | fluorodeoxyglucose (18F-FDG), GLUNEKTIK; SYNEKTIK | Anna Raciborska, Maria Sklodowska-Curie National Research Institute of Oncology, Łukasiewicz Research Network, Wrocław University of Environmental and Life Sciences | Histiocytosis | 03/26 | 03/26 | | |
TRAM, NCT04943224: Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients |
|
|
| Recruiting | 2 | 12 | Europe | Trametinib, Mekinist | Anna Raciborska, Maria Sklodowska-Curie National Research Institute of Oncology, Łukasiewicz Research Network, Wrocław University of Environmental and Life Sciences | Histiocytosis | 03/26 | 03/26 | | |
BRAVO, NCT04943198: Optimization of the Time and Dosage of Vemurafenib in BRAF Positive Juvenile Patients With Refractory Histiocytosis |
|
|
| Recruiting | 2 | 25 | Europe | Vemurafenib, Zelboraf | Anna Raciborska, Maria Sklodowska-Curie National Research Institute of Oncology, Łukasiewicz Research Network, Wrocław University of Environmental and Life Sciences | Histiocytosis | 03/26 | 03/26 | | |
NCT05968768: To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly) |
|
|
| Recruiting | 2 | 24 | Europe | Naxitamab, danyelza | Anna Raciborska, Wroclaw Medical University | Ewing Sarcoma | 05/27 | 07/28 | | |
| Recruiting | 1/2 | 30 | Europe | Regorafenib, Stivarga | Institute of Mother and Child, Warsaw, Poland, Maria Sklodowska-Curie National Research Institute of Oncology | Osteosarcoma, Ewing Sarcoma of Bone | 09/25 | 12/25 | | |
| Tubek, Stanislaw |
NCT05080478: Effects of P2Y12 Receptor Inhibitors on Central and Peripheral Chemoreceptors' Sensitivity |
|
|
| Recruiting | N/A | 50 | Europe | Clopidogrel, Ticagrelor | Wroclaw Medical University | Dyspnea | 08/22 | 08/22 | | |
| Protasiewicz, Marcin |
| Recruiting | N/A | 768 | Europe, RoW | Myval THV Series, Myval/Myval Inception THVs or any subsequent advanced version commercially available at the study site., Contemporary Valves (Sapien THV Series and Evolut THV Series), Sapien THV Series (Sapien 3/Sapien 3 Ultra THVs) and Evolut THV Series (Evolut R/Evolut PRO THVs ) or any subsequent advanced version commercially available at the study site. | Meril Life Sciences Pvt. Ltd. | Aortic Valve Stenosis | 03/24 | 12/33 | | |
| Recruiting | N/A | 150 | Europe, Canada, RoW | Elective redo transcatheter aortic valve implantation (redo-TAVI), redo-TAVI, redo-TAVR, Valve-in-Valve (ViV), TAV-in-TAV, TAVR-in-TAVR, Revalve | Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences | Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction, Prosthesis Failure | 09/25 | 12/26 | | |
| Biegus, Jan |
NCT06725927: Vaccination Against Influenza Pre-discharge in Heart Failure |
|
|
| Not yet recruiting | 4 | 200 | NA | Influenza vaccination | Wroclaw Medical University | Heart Failure | 11/25 | 12/25 | | |
SOLVRED-AHF, NCT05962255: Sodium Chloride vs. Glucose Solute as a Volume Replacement Therapy During Decongestion in Acute Heart Failure |
|
|
| Completed | 3 | 50 | Europe | Furosemide intravenous infusion, Continous intravenous infusion of 0.9% Sodium Chloride solution, Continous intravenous infusion of 5% Glucose solution | Wroclaw Medical University | Acute Heart Failure, Congestion, Heart Failure | 04/24 | 04/24 | | |
VACCINE-CHF, NCT06259487: Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis. |
|
|
| Recruiting | N/A | 250 | Europe | Coordinated Vaccination, Following recommendations | Wroclaw Medical University | Heart Failure, RSV Infection, Influenza, Vaccines | 06/24 | 07/24 | | |
FASTR-EU, NCT06362668: EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System |
|
|
| Recruiting | N/A | 30 | Europe | Reprieve Decongestion Management System, Diuretic (furosemide, bumetanide, torsemide, hydrochlorothiazide, and/or acetazolamide) | Reprieve Cardiovascular, Inc | Acute Decompensated Heart Failure | 10/24 | 12/24 | | |
| Recruiting | N/A | 50 | Europe, RoW | WhiteSwell eLym System | WhiteSwell, Limited | Heart; Decompensation, Congestive | 06/25 | 12/25 | | |
| Zimoch, Wojciech |
| Recruiting | N/A | 250 | Europe, RoW | CTO PCI using DCB-only strategy | National Institute of Cardiology, Warsaw, Poland | Coronary Artery Disease, Total Occlusion of Coronary Artery | 02/25 | 03/25 | | |
| Drozd, Jakub |
| Recruiting | N/A | 250 | Europe, RoW | CTO PCI using DCB-only strategy | National Institute of Cardiology, Warsaw, Poland | Coronary Artery Disease, Total Occlusion of Coronary Artery | 02/25 | 03/25 | | |
| Bardowska, Klaudia |
NCT06235853: Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer |
|
|
| Completed | N/A | 240 | Europe | Blood serum: sUPAR, PAI-1, IL-8., Urine: IL-8, APOE, VEGF. | Wroclaw Medical University | Non-muscle Invasive Bladder Cancer, Cystoscopy, Recurrence, Progression, Bladder Cancer, Biomarkers | 12/22 | 04/23 | | |
